A veteran-led nonprofit proves its psychedelic healing model works. The VA says it doesn’t even meet “threshold requirements.”
This week’s trip: new LSD data conflicts across trials, microdosing takes a complicated turn, and anecdotal reports keep the debate alive.
This week’s trip: ibogaine policy takes center stage, veterans drive the movement for change, and psilocybin meets the science of longevity.
This week’s trip: the world unites for healing, Hollywood resurrects the government's use of LSD and mind control, and scientists keep finding proof that consciousness is anything but ordinary.
This week’s trip: the “God Molecule” steps into the spotlight, tech’s hidden visionary meets transcendence, and researchers uncover new ways to unlock the brain’s potential.
This one’s about you — the community that’s turning curiosity into connection and reshaping the future of psychedelics together.
This week’s trip: ancient elites brewed psychedelic beer to build empires, Spain embraces medical cannabis, and psilocybin research reveals deeper paths to relief.
This week’s trip: new science on mushrooms, stroke recovery, and hikrodosing — plus a dive into the most historic psychedelic moments of October.
In the shadows of a relentless disease, light is breaking through in unexpected ways.
This week’s trip: new research shows psychedelics may help heal concussions, lawmakers weigh psilocybin, and the world prepares for Global Psychedelic Week.
To understand the psychedelic movement down under, we reached out to one of Australia’s own: Angus, creator of PsychedNation, whose work offers a front-row seat to a culture in transition.
This week’s trip: clinical proof LSD eases anxiety, the FDA reveals why MDMA was blocked, and Europe takes a historic leap forward.
